Cytotoxicity testing is a critical endpoint for all medical devices that come into contact with patients or users, regardless of the type or duration of contact. This test is an in vitro cell culture assay where an extract of the medical device is placed in contact with a mammalian fibroblast monolayer, and the viability of the cells is measured either qualitatively or quantitatively.
Cytotoxicity testing serves as an essential screening tool in the medical industry. It is particularly valuable when there are changes in materials or processing methods, or when evaluating the impact of device aging. The test helps to ensure that any alterations do not adversely affect the safety and biocompatibility of the medical device.
This webinar will delve into the fundamentals and applications of cytotoxicity testing. Participants will gain a comprehensive understanding of the test’s importance, methodology, and the role it plays in ensuring the safety of medical devices. The session will cover the process of conducting cytotoxicity tests, including how to prepare device extracts, conduct assays, and interpret results.
By understanding the principles and practices of cytotoxicity testing, attendees will be better equipped to apply this crucial assay in their work. This knowledge is essential for professionals involved in the design, development, and regulatory compliance of medical devices, helping to ensure that products are safe for patient use.